Jason M. Tanner

Jason M. Tanner, MD, PhD

Languages spoken: English, Spanish

Clinical Locations

South Jordan Health Center

South Jordan
801-213-4500

University of Utah Hospital

Emergency Medicine
Salt Lake City
801-581-2121

  • Dr. Jason Tanner is an Assistant Professor of Emergency Medicine with a dedicated focus on both cutting-edge molecular research and practical medical applications in challenging environments. His interests include studying molecular derangements present in emergent conditions including stroke, sepsis, and trauma.

    Dr. Tanner is also passionate about wilderness and austere medicine, and collaborates with search and rescue teams and EMS providers to develop innovative approaches for delivering high-quality medical care in remote and resource-constrained settings.

    Specialties

    Board Certification

    American Board of Emergency Medicine (Emergency Medicine)

  • Dr. Jason Tanner is an Assistant Professor of Emergency Medicine with a dedicated focus on both cutting-edge molecular research and practical medical applications in challenging environments. His interests include studying molecular derangements present in emergent conditions including stroke, sepsis, and trauma.

    Dr. Tanner is also passionate about wilderness and austere medicine, and collaborates with search and rescue teams and EMS providers to develop innovative approaches for delivering high-quality medical care in remote and resource-constrained settings.

    Board Certification and Academic Information

    Academic Departments Eccles Health Library -Primary
    Board Certification
    American Board of Emergency Medicine (Emergency Medicine)

    Education history

    Fellowship Wilderness Medicine - Yale School of Medicine Fellow
    Emergency Medicine - Yale School of Medicine Resident
    Doctoral Training Biochemistry - University of Utah Ph.D.
    Medicine - University of Utah School of Medicine M.D.
    Undergraduate International Studies - University of Utah B.A.

    Selected Publications

    Journal Article

    1. Chartash D, Sharifi M, Emerson B, Frank R, Schoenfeld EM, Tanner J, Brandt C, Taylor RA (2021). Documentation of Shared Decisionmaking in the Emergency Department. Ann Emerg Med, 78(5), 637-649. (Read full article)
    2. Theisen ER, Selich-Anderson J, Miller KR, Tanner JM, Taslim C, Pishas KI, Sharma S, Lessnick SL (2020). Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein. Epigenetics, 16(4), 405-424. (Read full article)
    3. Bensard CL, Wisidagama DR, Olson KA, Berg JA, Krah NM, Schell JC, Nowinski SM, Fogarty S, Bott AJ, Wei P, Dove KK, Tanner JM, Panic V, Cluntun A, Lettlova S, Earl CS, Namnath DF, Vzquez-Arregun K, Villanueva CJ, Tantin D, Murtaugh LC, Evason KJ, Ducker GS, Thummel CS, Rutter J (2019). Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier. Cell Metab, 31(2), 284-300.e7. (Read full article)
    4. Tanner JM, Bensard C, Wei P, Krah NM, Schell JC, Gardiner J, Schiffman J, Lessnick SL, Rutter J (2017). EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma. Mol Cancer Res, 15(11), 1517-1530. (Read full article)
    5. Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, Flores A, Mohlman J, Sorensen LK, Earl CS, Olson KA, Miao R, Waller TC, Delker D, Kanth P, Jiang L, DeBerardinis RJ, Bronner MP, Li DY, Cox JE, Christofk HR, Lowry WE, Thummel CS, Rutter J (2017). Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nat Cell Biol, 19(9), 1027-1036. (Read full article)
    6. Sankar S, Tanner JM, Bell R, Chaturvedi A, Randall RL, Beckerle MC, Lessnick SL (2013). A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma. Mol Cell Biol, 33(22), 4448-60. (Read full article)
    7. Zhang QJ, Holland WL, Wilson L, Tanner JM, Kearns D, Cahoon JM, Pettey D, Losee J, Duncan B, Gale D, Kowalski CA, Deeter N, Nichols A, Deesing M, Arrant C, Ruan T, Boehme C, McCamey DR, Rou J, Ambal K, Narra KK, Summers SA, Abel ED, Symons JD (2012). Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes, 61(7), 1848-59. (Read full article)
    8. Tanner JM, Kearns DT, Kim BJ, Sloan C, Jia Z, Yang T, Abel ED, Symons JD (2010). Fasting-induced reductions in cardiovascular and metabolic variables occur sooner in obese versus lean mice. Exp Biol Med (Maywood), 235(12), 1489-97. (Read full article)
    9. Zhang QJ, McMillin SL, Tanner JM, Palionyte M, Abel ED, Symons JD (2009). Endothelial nitric oxide synthase phosphorylation in treadmill-running mice: role of vascular signalling kinases. J Physiol, 587(Pt 15), 3911-20. (Read full article)
    10. Symons JD, McMillin SL, Riehle C, Tanner J, Palionyte M, Hillas E, Jones D, Cooksey RC, Birnbaum MJ, McClain DA, Zhang QJ, Gale D, Wilson LJ, Abel ED (2009). Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ Res, 104(9), 1085-94. (Read full article)

    Commentary

    1. Tanner JM, Rutter J (2016). You Are What You Eat... or Are You? Dev Cell, 36(5), 483-5. (Read full article)